$PRAN Recent News U.S. stocks rise; S&P 500, Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board

Sep 5, 2014 at 10:02 AM

$PRAN Recent News

U.S. stocks rise; S&P 500, Nasdaq notch quarterly gains 4:47 p.m. March 31, 2014 - Anora Mahmudova
Keurig biggest S&P 500 loser; BlackBerry extends losses 3:30 p.m. March 31, 2014 - Sue Chang
Biotech's shares fall 70% on tests 12:39 p.m. March 31, 2014 - Russ Britt
U.S. stock futures extend gains ahead of Yellen 8:58 a.m. March 31, 2014 - Barbara Kollmeyer
U.S.-listed shares of Prana sink after drug trial 7:50 a.m. March 31, 2014 - Saumya Vaishampayan
Prana sinks 62% after Alzheimer's study fails 7:22 a.m. March 31, 2014 - Barbara Kollmeyer
U.S. stocks edge up; Nasdaq gains for 8th day in a row 5:38 p.m. Feb. 18, 2014 - Anora Mahmudova
Forest Laboratories, Actavis surge on buyout deal 5:11 p.m. Feb. 18, 2014 - Sue Chang
S&P 500, Nasdaq extend win streaks but Dow dips: stock market live blog recap 5:06 p.m. Feb. 18, 2014 - blogs.marketwatch.com
Prana's wild ride continues with shares surging on drug test results 4:24 p.m. Feb. 18, 2014 - Russ Britt
Prana's Huntington disease therapy meets endpoints 12:51 p.m. Feb. 18, 2014 - MarketWatch.com
Prana Biotechnology up 19% in premarket 9:58 a.m. Dec. 6, 2012 - Steve Gelsi
Prana has OK for Alzheimer's study; shares rise 2:30 p.m. Nov. 22, 2011 - MarketWatch.com
Monday’s biggest gaining and declining stocks 4:30 p.m. Sept. 19, 2011 - Laura Mandaro
Prana, European drug makers lead rally 3:26 p.m. April 20, 2011 - Val Brickates Kennedy
Prana climbs 14% on business update 11:18 a.m. April 20, 2011 - Val Brickates Kennedy
Xoma, Prana lead biotech stocks south 1:19 p.m. March 23, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:56 p.m. March 22, 2011 - Kate Gibson
Prana shines in drugstock trading 11:02 a.m. March 22, 2011 - Val Brickates Kennedy
Prana rockets on Alzheimer's study 10:20 a.m. March 22, 2011 - Val Brickates Kennedy

Why Prana Biotechnology (PRAN) Stock Is Surging Today 16 min ago - TheStreet.com
Why Prana Biotechnology (PRAN) Stock Is Surging Today 2:05 p.m. July 17, 2014 - TheStreet.com
Prana shares up premarket on clinical trial update 9:22 a.m. July 17, 2014 - Seeking Alpha
Prana Biotechnology (PRAN) Stock Suddenly Surges 3:28 p.m. May 27, 2014 - TheStreet.com
Prana Biotechnology Is Still A Short After Recent Alzheimer's Failure 4:15 p.m. April 14, 2014 - Seeking Alpha
Are These Three Biotech Companies Still Worth A Gamble? 11:16 a.m. April 14, 2014 - Seeking Alpha
Prana collapses after trial fails 6:57 a.m. March 31, 2014 - Seeking Alpha
Prana Biotechnology - A Gamble Worth Taking For Both Long- And Short-Term Investors 3:49 p.m. March 20, 2014 - Seeking Alpha
Prana to join Aussie index for top 300 companies 10:00 a.m. March 11, 2014 - Seeking Alpha
Alzheimer's Research Stocks - Technical And Other Considerations 9:38 a.m. March 7, 2014 - Seeking Alpha
Prana Biotech Alzheimer approach supported by study 11:49 a.m. March 6, 2014 - Seeking Alpha
Alzheimer's Dementia: Eli Lilly's Solanezumab Or Prana's PBT2, Which Would You Take? 4:24 p.m. March 4, 2014 - Seeking Alpha
Prana: Right Drug, Wrong Dose 10:38 a.m. March 3, 2014 - Seeking Alpha
Bipolar Prana: PBT2 For Alzheimer's Dementia, Implications Of The Upcoming IMAGINE Trial Results 7:45 a.m. March 1, 2014 - Seeking Alpha
Following The Latest In Alzheimer's Research As An Investor 11:12 a.m. Feb. 24, 2014 - Seeking Alpha
Positive Phase 2 Results For Prana Biotechnology In Huntington's Disease: Behind The Smoke And Mirrors 1:45 p.m. Feb. 22, 2014 - Seeking Alpha
SA PRO: Top Long And Short Ideas, Thursday February 20 8:30 a.m. Feb. 21, 2014 - Seeking Alpha
Prana Biotechnology And MannKind Corp.: Bad News Obeys Its Own Special Laws 1:33 p.m. Feb. 20, 2014 - Seeking Alpha
Company news for February 19, 2014 - Corporate Summary 11:06 a.m. Feb. 19, 2014 - Zacks.com
Synthetic Biologics Under The Radar With Upcoming Multiple Sclerosis Data Catalyst 8:55 a.m. Feb. 19, 2014 - Seeking Alpha

Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease 7:45 a.m. Today - PR Newswire - PRF
Prana Alzheimer's disease Development Program update 4:10 p.m. July 17, 2014 - PR Newswire - PRF
Biotech Equities Technical Momentum -- Research on Organovo, Prana Biotechnology, Isis Pharma, and Pharmacyclics 7:04 a.m. July 14, 2014 - PR Newswire - PRF
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stock Watchout on Biotech Industry -- Research on Isis Pharma, Pharmacyclics, Amarin, and Prana Biotechnology 7:10 a.m. June 11, 2014 - PR Newswire - PRF
Biotech Equities Coverage -- Research on Isis Pharma, Pharmacyclics, Prana Biotech, and United Therapeutics 11:29 a.m. May 19, 2014 - PR Newswire - PRF
World leader in movement disorders Professor Ira Shoulson joins Prana Board 7:30 a.m. May 14, 2014 - PR Newswire - PRF
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Zeldes Haeggquist & Eck LLP Announces Investigation of Prana Biotechnology Limited 9:03 a.m. April 23, 2014 - BusinessWire - BZX
Prana Biotechnology Stock Hits New Low 10:47 a.m. April 16, 2014 - ACCESSWIRE
FDA Panel Grants Market Approval of MannKind Corp.'s Inhalable Insulin 9:49 a.m. April 2, 2014 - ACCESSWIRE
Coca-Cola Falls as Soda Sales Drop for 9th Straight Year 2:00 a.m. April 1, 2014 - ACCESSWIRE
Prana Biotechnology announces preliminary results of Phase 2 IMAGINE trial of PBT2 in Alzheimer's disease 7:05 a.m. March 31, 2014 - PR Newswire - PRF
Biotech Equities Technical Study -- Research on Prana Biotechnology, Amarin, United Therapeutic, and OPKO Health 12:19 p.m. March 28, 2014 - PR Newswire - PRF
Huntington's Reviewed by NeuroPerspective 9:30 a.m. March 4, 2014 - PR Newswire - PRF
Forest Labs to be acquired by Actavis for $25 billion while Prana Biotech surges on drug results 1:23 a.m. Feb. 19, 2014 - ACCESSWIRE
Prana Meets Primary Endpoint in Phase 2 REACH2HD Clinical Study of PBT2 for Treating Huntington Disease 7:02 a.m. Feb. 18, 2014 - PR Newswire - PRF
Products Recall, Stock Price Updates, Technology Solution Deployment, Update on Extension Trial, and Donations - Research Report on Alexion Pharma, Questcor, BioMarin Pharma, Allscripts, and Prana 9:00 a.m. Dec. 20, 2013 - PR Newswire
Prana Provides Update on PBT2 Alzheimer's Disease Extension Trial 10:03 a.m. Dec. 10, 2013 - Marketwire
Prana Completes PBT2 Dosing in IMAGINE Alzheimer's Disease Clinical Trial 10:02 a.m. Dec. 9, 2013 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Grovenstein Earns Top Franchisee Honor from IFA

A Well-Earned Accolade in Franchising When you've got your finger on the pulse of the franchise business, it’s hard to ignore the likes of Rebecca Grovenstein snagging the IFA Franchisee of the Year award. Running a business ain't for the faint of heart, let alone steering multiple franchises to success. Grovenstein's operations of Lightbridge Academy in Apex and Holly...

Singlewire's Alert Badge Wins Vision Award in 2026

A Badge That Reshapes Communication Safety You might think a simple badge wouldn't earn much fanfare, but here we are — the InformaCast Wearable Alert Badge from Singlewire Software has snagged a prestigious spot at FacilitiesNet's 2026 Vision Awards. What makes this badge special? Well, it's not just a bauble to pin on your lapel; it's a deceptively simple yet powerful...

Telit Cinterion Secures U.S. Manufacturing with PA Facility

Telit Cinterion Takes a Bold Step in U.S. Manufacturing Here's a move you don't see every day: Telit Cinterion, one of the leading players in the IoT scene, is planting its flag firmly in the good ol' U.S. of A. They're ramping up to start churning out 4G and 5G IoT modules right on American soil by October 2026. This isn't just a small-scale ambition, folks. We're...

Vertiv's Bold $1.45B Buyout to Enhance AI Data Centers

Vertiv Snatches Up UtilityInnovation Group for $1.45 Billion Throw a stone into the tech sector, and it's bound to hit something about AI or data centers these days. Well, Vertiv Holdings Co. (NYSE: VRT) has made a splash by announcing a meaty $1.45 billion transaction to acquire UtilityInnovation Group (UIG). This move isn't just a bid to dust off the company's resume;...

Plan A Bets on AI in High-Stakes M&A Arena

Digging Deeper with AI in M&A Deals Picture this: you’re at the table with a fat corporate M&A deal, eyes darting as you decipher numbers and nods, when out swings Plan A Technologies with their new ace up their sleeve—a stealth AI assessment tool armed to sharpen their technical due diligence. Unmasking the Tech Jigsaw Las Vegas-based Plan A Technologies hasn't just...

Spencer Spirit Completes Hot Topic Acquisition

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Soleno Therapeutics Faces Shareholder Legal Scrutiny

Legal Storm Brews for Soleno's Execs When you see Kuehn Law stepping into the ring, you know someone’s ruffling feathers. And this time, the target is Soleno Therapeutics (NASDAQ:SLNO), a name that might ring bells for tech folks dabbling in biotech. They’re under the spotlight because a federal securities lawsuit claims a questionable playbook was in the shuffle....

Flotek Faces Lawsuit: Investors Urged to Act Fast

Flotek's Current Storm: Gather Your Wits, Shareholders If you've staked your hard-earned cash into Flotek Industries, Inc. (FTK), it's high time to buckle up. Those court-blaring sirens aren’t a drill: we're talking class-action territory, people. The Law Offices of Howard G. Smith sound the alarm, calling on investors who’ve had their financial feathers singed to...

BlueSky Enters Nashville: In-Home Vet Care Begins

Nashville Welcomes A New Wave of Pet Care In a world where convenience is king, BlueSky At-Home Veterinary Care is stepping up to the plate—or should I say, doorstep—by rolling out its fresh take on veterinary services in Nashville. Kicking off on September 15, 2026, this isn't just any ol' run-of-the-mill clinic opening. We're talking about vets coming straight to...